Search Within

Esther Naomi Drill

  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (21)
  3. Research Letter (1)
Groups
  1. Department of Medicine (49)
  2. Epidemiology and Biostatistics (49)
  3. Hematologic Malignancies, Division of (49)
  4. Principal Biostatisticians (49)
  5. Center for Hematologic Malignancies (46)
  6. Lymphoma (39)

More Groups

People
  1. Alison Moskowitz (26)
  2. Steven Horwitz (24)
  3. Andrew Zelenetz (23)
  4. Anita Kumar (23)
  5. Ariela Noy (22)
  6. Matthew Matasar (20)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (7)
  5. 2021 (9)
  6. 2020 (3)

More Years

Publications
  1. Blood (18)
  2. Haematologica (6)
  3. Journal of Clinical Oncology (5)
  4. Hematological Oncology (4)
  5. Blood Advances (2)
  6. Biology of Blood and Marrow Transplantation (1)

More Publications

Publishers
  1. American Society of Hematology (20)
  2. Ferrata Storti Foundation (6)
  3. American Society of Clinical Oncology (5)
  4. Wiley Blackwell (4)
  5. Nature Publishing Group (3)
  6. Elsevier Inc. (2)

More Publishers

Results (49)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Applying lymphgen classification to a clinically validated 400-gene targeted next-generation sequencing (NGS) panel in diffuse large b-cell lymphoma (DLBCL)
    Meeting Abstract

    Zhu, M.; Drill, E.; Joffe, E.; Arcila, M.; Dogan, A.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
    Journal Article

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Vardhana, S.; Ganesan, N.; Hancock, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Real-world assessment of patient care and practice efficiency with the introduction of subcutaneous rituximab
    Journal Article

    Drill, E.; Qiu, A.; Shapouri, S.; Tu My, T.; Ravelo, A.; Schade, J.; Dawson, K.; Matasar, M.
    Oncology (Norwalk) (2021)

    Fulltext@MSK | Save
  • IVAC with or without rituximab for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Journal Article

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma
    Meeting Abstract

    Khan, N.; Khimani, F.; Shustov, A. R.; Shadman, M.; Ruan, J.; Moskowitz, A. J.; Straus, D. J.; Kumar, A.; Sauter, C. S.; Zelenetz, A. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in patients with newly diagnosed early-stage, unfavorable-risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S. V.; Drill, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Cardiotoxicity risk in patients with non‐Hodgkin lymphoma receiving epoch after prior anthracycline exposure
    Meeting Abstract

    Buege, M. J.; Dao, P. H.; Drill, E.; Horwitz, S. M.; LeVoir, A.; Pak, T.; Peterson, T. J.; Matasar, M. J.
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • The combination of duvelisib and romidepsin (DR) is highly active against relapsed/refractory peripheral T‐cell lymphoma with low rates of transaminitis: Final results
    Meeting Abstract

    Horwitz, S. M.; Moskowitz, A. J.; Mehta‐Shah, N.; Jacobsen, E. D.; Khodadoust, M. S.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Myskowski, P.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue
    Journal Article

    Joffe, E.; Leyfman, Y.; Drill, E.; Rajeeve, S.; Zelenetz, A. D.; Lia Palomba, M.; Moskowitz, C. H.; Portlock, C.; Noy, A.; Horwitz, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save